Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies.
Tariot PN, Riviere ME, Salloway S, Burns JM, Snaedal JG, Borowsky B, Lopez CL, Liu F, Rouzade-Dominguez ML, Cazorla P, Mousseau MC, Arkuszewski M, Ricart J, Viglietta V, Sui Y, Caputo A, Langbaum JB, Reiman EM, Graf A.
Tariot PN, et al. Among authors: caputo a.
Alzheimers Dement. 2024 Nov;20(11):7745-7761. doi: 10.1002/alz.14237. Epub 2024 Sep 25.
Alzheimers Dement. 2024.
PMID: 39320017
Free PMC article.
Clinical Trial.